This inventor holds 1 USPTO granted patent. Top assignee: Australia Nuclear Science & Technology Organization. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: The Innovations of John M Sodeau
Introduction
John M Sodeau is an accomplished inventor based in Engadine, Australia. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative methods for treating technetium-containing solutions. His work is vital for enhancing the purity and concentration of radiopharmaceuticals used in medical applications.
Latest Patents
John M Sodeau holds a patent for the "Treatment of technetium containing solutions." This patent describes a method involving an initial aqueous pertechnetate solution with low electrolyte concentration. The process includes passing the solution through a bed of insoluble ion exchange material to adsorb the pertechnetate. Subsequently, an ionic eluant is used to remove the pertechnetate, resulting in a concentrated and pure eluate solution. This method is particularly valuable for treating eluates from portable technetium generators.
Career Highlights
Sodeau's career is marked by his dedication to advancing the field of nuclear science and technology. He works with the Australia Nuclear Science & Technology Organization, where he applies his expertise to develop innovative solutions for medical applications. His work has implications for improving the safety and efficacy of radiopharmaceuticals.
Collaborations
Throughout his career, John M Sodeau has collaborated with notable colleagues, including Phillip W Moore and Michael Shying. These collaborations have contributed to the advancement of research and development in the field of nuclear science.
Conclusion
John M Sodeau's contributions to the treatment of technetium-containing solutions highlight his innovative spirit and commitment to improving medical technologies. His work continues to influence the field of radiopharmaceuticals, ensuring safer and more effective treatments for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile